Slab51 Formulation
Science is key
SLAB51 is another specific 8-strain probiotic formulation developed by Prof. Claudio De Simone. While the SLAB51 formulation is similar to the DSF in terms of proportions and types of species, the fermentation process and the manufacturer differ. Thus, SLAB51 is a unique product.
The biological and immunological properties and the enzymatic activity of SLAB51 continue to be characterised through a growing number of publications. New mechanisms of action on the gut-brain axis and oxygen-sparing capacity have been elucidated in various clinical conditions such as Alzheimer’s disease, Parkinson’s disease, Lyme disease and COVID-19.
Veterinarians worldwide have also taken a significant interest in this probiotic formulation, and studies have been performed in different animal species.
Why probiotics?
The microorganisms living in your gut have numerous functions, the most important being the maintenance and integrity of the mucosal barrier, providing nutrients to the host, such as vitamins, and protecting against pathogens.
When beneficial bacteria are lost either through illness or treatments such as antibiotics, a state of dysbiosis is created. Probiotics can help replace the beneficial bacteria and restore the balance of your microflora.
SLAB51 is not just any probiotic.
Gut-Brain Axis
There exists a bidirectional communication network functionally linking the gut and the central nervous system (CNS), known as the gut-brain axis. The manipulation of intestinal microbiota with SLAB51 has been successfully investigated as a novel therapeutic strategy for CNS-associated disorders such as Alzheimer’s and Parkinson’s.
Lung-Brain Axis
More recently, this specific probiotic formulation has been shown to modulate the consumption of oxygen in the gut making more oxygen available for critical organs (i.e. brain, heart, liver). The “oxygen sparing effect” induced by SLAB51 has been scientifically proven in several studies, particularly in patients with COVID-19 infection.
Eight strains for teamwork
The strains contained in the SLAB51 blend have been selected for their specific individual characteristics and their capacity to work in synergy, achieving what individual strains or other strain combinations cannot.
The strains have been the object of numerous experimental and clinical studies confirming their safety and efficacy, particularly in the gut-brain and gut-lung axes.
A good probiotic is not identified by the number of strains or their concentrations; what actually matters is the clinical evidence that such a combination brings.
SLAB51 is available in various concentrations, from 10 billion to 800 billion active and vital bacteria per capsule or sachet. Consider that the number of microorganisms inhabiting the gastrointestinal tract is estimated to exceed 1014. In the colon alone, there can be up to 1012 cells per gram of intestinal contents. The proposed concentrations are necessary to colonise the gut and significantly modify the gut flora in specific patient groups.
Study confirms Probiotic SLAB51 benefits COVID-19 hypoxic patients
Study confirms Probiotic SLAB51 benefits COVID-19 hypoxic patients Successful management of acute respiratory distress syndrome (ARDS) resulting [...]
How probiotic Slab51 affects lipid metabolism in Alzheimer’s Disease
Preclinical and human studies have demonstrated the link between unbalanced gut microbiota and Alzheimer’s Disease (AD). However, [...]
Probiotic Slab51 reduces chronic fatigue in patients following Covid hospitalization
Researchers reveal that long term effects of post-COVID fatigue are currently under reported and poorly understood against [...]
New insights confirm neuroprotective and anti-inflammatory effects of SLAB51
Gut dysbiosis is an established key player in the pathogenesis and/or development of age-related neurodegeneration, such as [...]
Add-on probiotic therapy reduces seizures for drug-resistant epilepsy patients
Reduction in seizures following add-on probiotic therapy in patients with drug-resistant epilepsy. Drug-resistant epilepsy (DRE) occurs in [...]
The oxygen sparing effect of bacteriotherapy in COVID-19 (1)
The probiotic Slab51 (Sivomixx®800, Ormendes, Switzerland) has been evaluated in sixty-nine adult COVID-19 patients with a confirmed diagnosis [...]
When an efficacious food supplement* suffers from being just a “probiotic”
Probiotics are considered the «snake oil» of the millennium, and doctors are reluctant to explore their full potential. [...]
The probiotic blend Slab51 reduces the side effects from chemotherapy
Chemotherapeutics are commonly used for tumor therapy, but they trigger numerous side effects which put into perspective [...]
Improved host response to Sars-Cov-2 infection when the gut flora is balanced
The Sars-Cov-2 pandemic has shown that Covid-19 can move from the respiratory system, most vulnerable to the [...]
High concentration probiotics in the arsenal to fight the Covid-19
A new prospective in Covid-19 management comes from the journal Frontiers in Medicine. Understanding the invasive process [...]
Probiotics: a valuable add-on in SARS-CoV-2 infection
The Sars-Cov-2 coronavirus pandemic has spread widely around the world, causing often times serious clinical conditions such [...]
23 novel genera, emended description of the genus Lactobacillus
Since the description of the first Lactobacillus species, Lactobacillus delbrueckii, in 1901, over 260 species were assigned to this genus until [...]
Probiotics helping Parkinson’s disease patients
Parkinson is a neurodegenerative disorder characterized by motor and non-motor symptoms (such as depression, abnormalities in the [...]
Intestinal microbiome and neurological disorders, a promising future1
We know that the bacterial colonization plays a key role for the intestinal health, but we now [...]
A mouse model of lupus benefited from probiotic treatment during pregnancy and breastfeeding1
Dysbiosis of gut microbiota exists in the pathogenesis of many autoimmune diseases, including systemic lupus erythematosus (lupus). [...]
Modulation of the intestinal microbiota to improve diabetic patients’ health
An interesting study has been presented at the annual EASD meeting (European Association for the Study of Diabetes) [...]
Antimicrobial resistance: act now
Since their discovery, antibiotics have served as the cornerstone of modern medicine. However, the persistent overuse and misuse [...]
Highly concentrated probiotics to improve cognitive function
Recent evidences confirm that probiotics can modulate the intestinal microbiota, intestinal permeability and immune response: hence, the [...]
Autoimmune responses against intestinal bacteria are linked with type 1 diabetes
Microbiome sequence analyses have suggested that changes in gut bacterial composition are associated with autoimmune disease in [...]
High concentration probiotics for healthier aging
The human gut microbiota is a huge ecosystem that provides numerous functions for host development, immune system, and [...]
The microbiome of patients with Lupus influences their immunity
Patients with Systemic Lupus Erythematosus (SLE) have a particular intestinal microbiome characterized by a deep dysbiosis the intensity [...]
Screening for rheumatoid arthritis passes through the microbiome of our mouth
The key to arthritis management is early diagnosis and treatment to prevent further joint destruction and maximize [...]
And psychiatrists discovered the microbiota
The modalities with which the organism establishes its behaviour in the environment that surrounds it also passes [...]
Does the treatment of obesity and diabetes go through the intestine? 1
In this paper from Harvard, the group led by Ronald Kahn wondered why obesity and diabetes were [...]
Transient Osmotic Perturbation Causes Long-Term Alteration to the Gut Microbiota1
Conditions of food intolerance or malabsorption, but above all the use of laxatives, can cause an osmotic [...]
Where to purchase Slab51 Formulation?